Unique Pharmaceutical Laboratories
A single plant registered with the FDA to make drugs for the US market. Below is where it is and the drugs whose FDA labels list this site as performing a manufacturing step — so if this plant has a problem, these are the products that could be affected.
- Country
- India
- Registered address
- Plot No. 215-219, G.I.D.C Industrial Area, Bharuch, 394116, India (IND)
- Operations here
- analysismanufacturepack
- FDA identifiers
- FEI 3003053502 · DUNS 650434645
FDA inspection history
Outcomes of closed FDA inspections at this site (drug and biologic program areas).
- VAIDrug Quality Assurance2022-10-23
- VAIDrug Quality Assurance2020-02-07
- VAIDrug Quality Assurance2018-08-24
- NAIDrug Quality Assurance2016-06-24
- VAIDrug Quality Assurance2013-10-18
- NAIDrug Quality Assurance2011-12-02
Drugs this plant is listed as making
15 distinct drugs across 48 products name this site in their FDA label.
- AtenololRising Pharma Holdings, Inc.
- Bisoprolol FumarateRising Pharma Holdings, Inc.
- ciprofloxacinRising Pharma Holdings, Inc.
- Clomipramine HydrochlorideRising Pharma Holdings, Inc.
- ClotrimazoleRising Pharma Holdings, Inc.
- Diclofenac SodiumRising Pharma Holdings, Inc.
- Doxepin hydrochlorideRising Pharma Holdings, Inc.
- GlipizideRising Pharma Holdings, Inc.
- Lithium CarbonateRising Pharma Holdings, Inc.
- Midodrine HydrochlorideUmasuto, LLC
- Oxybutynin ChlorideRising Pharma Holdings, Inc.
- TinidazoleRising Pharma Holdings, Inc.
- Tolterodine TartrateRising Pharma Holdings, Inc.
- VenlafaxineRising Pharma Holdings, Inc.
Sources:the establishment's name, address, and country from FDA's Drug Establishments Current Registration Site (DECRS); the drug-to-facility links from DailyMed SPL drug labels, matched by the facility's DUNS number; inspection outcomes from the FDA Data Dashboard, matched by FEI; shortage status from FDA's drug shortage database. More on how this is built. Educational only.